Njegica Jojic

Statistics

Publications

Citations

254

H-Index

Active since

2008

Affiliations

Kliničko Bolnički Centar Zvezdara(Current)

Njegica Jojic is an author at Kliničko Bolnički Centar Zvezdara specializing in inflammatory bowel disease, ulcerative colitis pharmacotherapy, and inflammatory bowel disease therapy.

Publications per year

2008–2016

Publications

Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis

William J. Sandborn, Brian G. Feagan, E. А. Belousova et al. · Gastroenterology · 2009 · 167 citations

Medicine, Pharmacology, Pharmacotherapy +9

The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients

Marijana Protić, Frank Seibold, Alain Schoepfer et al. · Journal of Crohn s and Colitis · 2014 · 34 citations · Full text

Pharmacy, Pharmacotherapy, Gastroenterology +11

Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease

Benjamin Alexandre, Yves Vandermeeren, Olivier Dewit et al. · Journal of Crohn s and Colitis · 2016 · 29 citations · Full text

Medicine, Immunology, Neurology +15

Different levels of humoral immunoreactivity to different wheat cultivars gliadin are present in patients with celiac disease and in patients with multiple myeloma

Aleksandra Konić‐Ristić, Dejan Dodig, S Jelić et al. · BMC Immunology · 2009 · 13 citations · Full text

Life Sciences, Immunology, Pathology +16

702 Efficacy and Safety of Delayed-Release Oral mesalamine At 4.8g/D (800mg Tablet) in the Treatment of Moderately Active Ulcerative Colitis: Results of the Ascend III Study

William J. Sandborn, Brian G. Feagan, E. А. Belousova et al. · Gastroenterology · 2008 · 11 citations

Medicine, Pharmacology, Pharmacotherapy +11

1–5 of 5